Michael Amoroso
Chief Executive Officer en PRECISION BIOSCIENCES, INC. .
Fortuna: 735 212 $ al 31/03/2024
Perfil
Michael Amoroso is currently the President, Chief Executive Officer & Director at Precision BioSciences, Inc. He is also the Chairman at Abeona Therapeutics, Inc. Previously, he worked as the SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. Michael completed his undergraduate degree at Rider University and holds an MBA from The Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
01/03/2024 | 79 187 ( 0.29% ) | 574 106 $ | 31/03/2024 | |
18/04/2024 | 11 881 ( 0.18% ) | 161 106 $ | 31/03/2024 |
Cargos activos de Michael Amoroso
Empresas | Cargo | Inicio |
---|---|---|
ABEONA THERAPEUTICS INC. | Chairman | 14/10/2021 |
PRECISION BIOSCIENCES, INC. | Chief Executive Officer | 15/10/2021 |
Antiguos cargos conocidos de Michael Amoroso.
Empresas | Cargo | Fin |
---|---|---|
KITE PHARMA INC | Corporate Officer/Principal | 01/01/2020 |
Formación de Michael Amoroso.
Rider University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Amoroso